Characterization of Oxaliplatin−DNA Adduct Formation in DNA and Differentiation of Cancer Cell Drug Sensitivity at Microdose Concentrations-Reference-Cited by-同舟云学术

Characterization of Oxaliplatin−DNA Adduct Formation in DNA and Differentiation of Cancer Cell Drug Sensitivity at Microdose Concentrations

Published:2007-11-15 Issue:12 Volume:20 Page:1745-1751
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Hah Sang Soo¹,Sumbad Rhoda A.¹,de Vere White Ralph W.¹,Turteltaub Kenneth W.¹,Henderson Paul T.¹

Affiliation:

1. Chemistry, Materials, Earth and Life Sciences Directorate and Center for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, 7000 East Avenue, L-452, Livermore, California 94551, and Department of Urology, School of Medicine, University of California, Sacramento, California 95817

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx700376a

Reference41 articles.

1. Oxaliplatin

2. FDA Drug Approvals List (online).http://www.fda.gov/cder/foi/label/2002/21492lbl.pdf(Accessed November 28, 2003) .

3. Cellular processing of platinum anticancer drugs

4. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts

5. Particular aspects of platinum compounds used at present in cancer treatment

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocarriers for platinum drug delivery;Biomedical Technology;2023-06

2. Development of Comprehensive Ultraperformance Liquid Chromatography–High-Resolution Mass Spectrometry Assays to Quantitate Cisplatin-Induced DNA–DNA Cross-Links;Chemical Research in Toxicology;2023-05-19

3. Effect of Severe Renal Dysfunction on the Plasma Levels of DNA-Reactive Platinum after Oxaliplatin Administration;Biological and Pharmaceutical Bulletin;2023-02-01

4. Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives;International Journal of Molecular Sciences;2022-12-06

5. Development of Comprehensive Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry Assays to Quantitate Cisplatin-Induced DNA-DNA Cross-Links;2022-09-28